Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,141,040
-$27,453 QoQ
Shares Held
3,151
-5.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#1,613
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Core Alternative Capital holds $26,259,704 across 8 Drug Manufacturers - General names. AMGN ranks #4 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,154 | $9,436,001 | |
| 2 | LLY |
ELI LILLY & Co
|
7,645 | $9,169,643 | |
| 3 | MRK |
Merck & Co., Inc.
|
39,979 | $5,137,301 | |
| 4 | AMGN |
Amgen Inc
This page
|
3,151 | $1,141,040 | |
| 5 | ABBV |
AbbVie Inc.
|
2,976 | $748,880 | |
| 6 | PFE |
Pfizer Inc
|
13,063 | $314,557 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,189 | $276,558 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
620 | $35,724 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,141,040 | 3,151 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,168,493 | 3,321 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,195,663 | 3,653 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $943,959 | 3,345 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,145,040 | 4,101 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,591,708 | 5,109 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,381,728 | 9,138 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $3,523,044 | 10,934 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,205,264 | 13,459 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $5,225,232 | 18,378 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,225,557 | 25,087 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,630,208 | 35,832 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $8,902,557 | 40,098 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $11,867,749 | 49,091 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $14,238,764 | 54,214 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $10,873,521 | 48,241 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $7,113,605 | 29,238 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $6,321,174 | 26,140 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $8,163,486 | 36,287 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,408,726 | 34,840 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $7,528,462 | 30,886 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $6,385,459 | 25,664 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $5,653,043 | 24,587 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,521,626 | 21,725 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $5,821,260 | 24,681 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $4,763,546 | 23,497 | Shares | Sole | 2020-06-09 | |
| No filing history on record for this holder in this stock. | ||||||